Wordt geladen...
Advances in the use of Natural Receptor- or Ligand-Based Chimeric Antigen Receptors (CARs) in haematologic malignancies
Chimeric antigen receptors (CAR)-T cell therapy has recently made promising advances towards treatment of B-cell malignancies. This approach makes use of an antibody-derived single chain variable fragment (scFv)-based CAR to target the CD19 antigen. Currently scFvs are the most common strategy for c...
Bewaard in:
| Gepubliceerd in: | Best Pract Res Clin Haematol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6428197/ https://ncbi.nlm.nih.gov/pubmed/29909918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beha.2018.03.003 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|